Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate

Gode F., Karagoz C., POSACI C., Saatli B., Uysal D., SEÇİL M., ...Daha Fazla

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.284, sa.4, ss.923-929, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 284 Sayı: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s00404-010-1790-9
  • Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.923-929
  • Anahtar Kelimeler: Polycystic ovary syndrome, Cardiovascular risk, Oral contraceptives, Metabolic risk, INTIMA-MEDIA THICKNESS, BRACHIAL ENDOTHELIAL FUNCTION, COMBINED ORAL-CONTRACEPTIVES, C-REACTIVE PROTEIN, INSULIN-RESISTANCE, YOUNG-WOMEN, NONOBESE WOMEN, METFORMIN, PREVALENCE, DISEASE
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

We aimed to evaluate the alteration of cardiovascular and metabolic risk parameters of polycystic ovary syndrome (PCOS) patients after a 6-month treatment with an oral contraceptive (OC) containing cyproterone acetate (CPA).